700 patients110,866 observations180 daysLIVE

Patient P-02305

Synthetic patientMETA-24 · Day 171 · 25–34 · M · baseline S20Open companion preview
Therapy response
Declining
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
24%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S20
  2. Day 12 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 12.

Primary contributors, last 14 days
  • Inflammatory activity+8
  • Treatment adherence+4
  • GI instability+3
  • Nutritional resilience+3

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients.

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Inflammatory signalling 60
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
      • WearableHRV 27 ms, trending down
    • Autonomic recovery 45
      • WearableResting HR 79 bpm
      • WearableShort sleep window
    • Mucosal barrier integrity 40
      • MicrobiomeAkkermansia low → thinner mucus layer
      • WearableSleep 6.0 h, below personal baseline
    • Butyrate / short-chain fatty acid production 35
      • MicrobiomeButyrate capacity 38/100
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Intermediate metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2.2 · butyrate capacity 38/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    31 ms
    Sleep
    6.4 h
    Steps
    5,623
    Resting HR
    76 bpm
    Daily log: GI score 29, nutritional resilience 62, adherence 92.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0203752%S04GI-04improved53
    P-0215852%S2043
    P-0251349%S16GI-04no change46
    P-0262249%S0750
    P-0205847%S05GI-04no change48
    P-0215047%S11HY-01improved45
    P-0222347%S20HY-01improved49
    P-0235147%S1651
    P-0241747%S18DT-01no change55
    P-0202346%S0746
    P-0220046%S1347
    P-0226246%S1653